97 related articles for article (PubMed ID: 16808814)
1. Attenuation of cysteinyl leukotrienes induces human mesenchymal stem cell differentiation.
Akino K; Mineda T; Mori N; Hirano A; Imaizumi T; Akita S
Wound Repair Regen; 2006; 14(3):343-9. PubMed ID: 16808814
[TBL] [Abstract][Full Text] [Related]
2. Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.
Vannella KM; McMillan TR; Charbeneau RP; Wilke CA; Thomas PE; Toews GB; Peters-Golden M; Moore BB
J Immunol; 2007 Dec; 179(11):7883-90. PubMed ID: 18025235
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages.
Ichiyama T; Kajimoto M; Hasegawa M; Hashimoto K; Matsubara T; Furukawa S
Clin Exp Allergy; 2007 Apr; 37(4):608-14. PubMed ID: 17430359
[TBL] [Abstract][Full Text] [Related]
4. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
Fang SH; Wei EQ; Zhou Y; Wang ML; Zhang WP; Yu GL; Chu LS; Chen Z
Neuroscience; 2006 Jul; 140(3):969-79. PubMed ID: 16650938
[TBL] [Abstract][Full Text] [Related]
7. [Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
Peng F; Fang SH; Zheng XL; Zhang WP; Lu YB; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):123-8. PubMed ID: 17443897
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice.
Hisada T; Salmon M; Nasuhara Y; Chung KF
Am J Respir Crit Care Med; 1999 Aug; 160(2):571-5. PubMed ID: 10430730
[TBL] [Abstract][Full Text] [Related]
9. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
10. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma.
Parameswaran K; Liang H; Fanat A; Watson R; Snider DP; O'Byrne PM
J Allergy Clin Immunol; 2004 Jul; 114(1):73-9. PubMed ID: 15241347
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs.
Fujita M; Yonetomi Y; Shimouchi K; Takeda H; Aze Y; Kawabata K; Ohno H
Eur J Pharmacol; 1999 Mar; 369(3):349-56. PubMed ID: 10225374
[TBL] [Abstract][Full Text] [Related]
12. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism.
Fukushima C; Matsuse H; Hishikawa Y; Kondo Y; Machida I; Saeki S; Kawano T; Tomari S; Obase Y; Shimoda T; Koji T; Kohno S
Int Arch Allergy Immunol; 2005 Feb; 136(2):165-72. PubMed ID: 15650315
[TBL] [Abstract][Full Text] [Related]
13. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
14. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
15. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
16. Distribution of specific binding sites for cysteinyl leukotriene 1 receptor antagonist in human nasal mucosa.
Shirasaki H; Kanaizumi E; Seki N; Kikuchi M; Watanabe K; Konno N; Himi T
Acta Otolaryngol; 2006 Sep; 126(9):948-51. PubMed ID: 16864492
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
19. Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).
Chebolu S; Wang Y; Ray AP; Darmani NA
Eur J Pharmacol; 2010 Feb; 628(1-3):195-201. PubMed ID: 19941848
[TBL] [Abstract][Full Text] [Related]
20. Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells.
Ishinaga H; Takeuchi K; Kishioka C; Suzuki S; Basbaum C; Majima Y
Pharmacology; 2005 Feb; 73(2):89-96. PubMed ID: 15475658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
